Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
NCT00042341
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia, Lymphoblastic, Acute, Pediatric
Interventions
DRUG:
clofarabine (IV formulation)
Sponsor
Genzyme, a Sanofi Company